Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| LENZ Therapeutics, Inc. | 764,127 | reported | 30 Sept 2025 | tx 13+14,051,446−34,510,334 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Sept 2025 | SALE | LENZ Therapeutics, Inc. | 34,405 | 45.35 USD | |
| 30 Sept 2025 | SALE | LENZ Therapeutics, Inc. | 49,701 | 45.35 USD | |
| 30 Sept 2025 | SALE | LENZ Therapeutics, Inc. | 83,066 | 46.41 USD | |
| 30 Sept 2025 | SALE | LENZ Therapeutics, Inc. | 57,502 | 46.41 USD | |
| 30 Sept 2025 | SALE | LENZ Therapeutics, Inc. | 177 | 47.01 USD | |
| 30 Sept 2025 | SALE | LENZ Therapeutics, Inc. | 123 | 47.01 USD | |
| 27 Jun 2025 | SALE | LENZ Therapeutics, Inc. | 200,000 | 30.47 USD | |
| 10 Jun 2025 | SALE | LENZ Therapeutics, Inc. | 350,000 | 29.00 USD | |
| 29 Jun 2021 | PURCHASE | LENZ Therapeutics, Inc. | 180,000 | 17.00 USD | |
| 29 Jun 2021 | CONVERSION | LENZ Therapeutics, Inc. | 1,527,719 | — | |
| 29 Jun 2021 | CONVERSION | LENZ Therapeutics, Inc. | 12,343,727 | — | |
| 29 Jun 2021 | CONVERSION | LENZ Therapeutics, Inc. | 30,019,945 | — | deriv |
| 29 Jun 2021 | CONVERSION | LENZ Therapeutics, Inc. | 3,715,415 | — | deriv |